1. Home
  2. KURA vs STKL Comparison

KURA vs STKL Comparison

Compare KURA & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • STKL
  • Stock Information
  • Founded
  • KURA 2014
  • STKL 1973
  • Country
  • KURA United States
  • STKL United States
  • Employees
  • KURA N/A
  • STKL N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • STKL Precious Metals
  • Sector
  • KURA Health Care
  • STKL Basic Materials
  • Exchange
  • KURA Nasdaq
  • STKL Nasdaq
  • Market Cap
  • KURA 793.2M
  • STKL 850.0M
  • IPO Year
  • KURA N/A
  • STKL N/A
  • Fundamental
  • Price
  • KURA $7.26
  • STKL $7.29
  • Analyst Decision
  • KURA Strong Buy
  • STKL Strong Buy
  • Analyst Count
  • KURA 11
  • STKL 4
  • Target Price
  • KURA $27.89
  • STKL $9.50
  • AVG Volume (30 Days)
  • KURA 1.7M
  • STKL 536.5K
  • Earning Date
  • KURA 02-25-2025
  • STKL 02-26-2025
  • Dividend Yield
  • KURA N/A
  • STKL N/A
  • EPS Growth
  • KURA N/A
  • STKL N/A
  • EPS
  • KURA N/A
  • STKL N/A
  • Revenue
  • KURA N/A
  • STKL $711,683,000.00
  • Revenue This Year
  • KURA N/A
  • STKL $15.65
  • Revenue Next Year
  • KURA $233.30
  • STKL $9.32
  • P/E Ratio
  • KURA N/A
  • STKL N/A
  • Revenue Growth
  • KURA N/A
  • STKL 16.96
  • 52 Week Low
  • KURA $6.98
  • STKL $4.88
  • 52 Week High
  • KURA $24.17
  • STKL $8.11
  • Technical
  • Relative Strength Index (RSI)
  • KURA 19.21
  • STKL 46.88
  • Support Level
  • KURA $7.02
  • STKL $7.14
  • Resistance Level
  • KURA $7.66
  • STKL $7.90
  • Average True Range (ATR)
  • KURA 0.34
  • STKL 0.28
  • MACD
  • KURA 0.07
  • STKL -0.07
  • Stochastic Oscillator
  • KURA 13.76
  • STKL 41.77

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.

Share on Social Networks: